David Turkaly
Stock Analyst at JMP Securities
(2.18)
# 2,755
Out of 4,941 analysts
139
Total ratings
38.89%
Success rate
-3.93%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Market Outperform | $50 → $35 | $19.66 | +78.03% | 11 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $53.90 | +35.44% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $13.81 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $61.87 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $52.23 | +91.46% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $243.76 | +14.87% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $13.77 | +81.55% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $28.75 | +91.30% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $101.82 | +22.77% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $435.80 | +14.73% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $376.61 | - | 3 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $119.64 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.60 | +337.50% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $14.16 | +83.62% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $15.22 | +110.25% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $7.27 | +120.08% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $2.27 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $3.86 | -22.28% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.59 | -41.79% | 1 | Oct 6, 2017 |
OrthoPediatrics
Aug 8, 2025
Maintains: Market Outperform
Price Target: $50 → $35
Current: $19.66
Upside: +78.03%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $53.90
Upside: +35.44%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $13.81
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $61.87
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $52.23
Upside: +91.46%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $243.76
Upside: +14.87%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $13.77
Upside: +81.55%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $28.75
Upside: +91.30%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $101.82
Upside: +22.77%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $435.80
Upside: +14.73%
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $376.61
Upside: -
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $119.64
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.60
Upside: +337.50%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $14.16
Upside: +83.62%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $15.22
Upside: +110.25%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $7.27
Upside: +120.08%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $2.27
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $3.86
Upside: -22.28%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.59
Upside: -41.79%